The Beast — Class I drug recall D-1321-2019
Terminated recall by Stiff Boy LLC, reported 2019-06-05, distributed nationwide. Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through F
| Recall number | D-1321-2019 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Stiff Boy LLC, Englewood, NJ, United States |
| Recall initiated | 2019-05-06 |
| Classified | 2019-06-05 |
| Reported by FDA | 2019-06-05 |
| Terminated | 2025-09-16 |
| Distributed | Nationwide (US) |
| Quantity | 1,000 boxes |
| Reason classes | undeclared allergen, unapproved product |
Product
The Beast, The Beast can be taken under the situation of Heart disease and even after drinking, 4600 mg X 4 Capsules per packet.
Reason for recall
Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1321-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.